{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["anti-inflammatory", "antidiabetic", "bone disorders", "flavonoids", "pharmaceutical"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33445965", "DateCompleted": {"Year": "2021", "Month": "09", "Day": "21"}, "DateRevised": {"Year": "2021", "Month": "09", "Day": "21"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "01", "Day": "15"}], "Language": ["eng"], "ELocationID": ["10.4155/ppa-2020-0026"], "Journal": {"ISSN": "2046-8962", "JournalIssue": {"Volume": "10", "Issue": "1", "PubDate": {"Year": "2021", "Month": "Jan"}}, "Title": "Pharmaceutical patent analyst", "ISOAbbreviation": "Pharm Pat Anal"}, "ArticleTitle": "Recent patents on therapeutic activities of xanthohumol: a prenylated chalconoid from hops (<i>Humulus lupulus</i> L.).", "Pagination": {"StartPage": "37", "EndPage": "49", "MedlinePgn": "37-49"}, "Abstract": {"AbstractText": ["There is expanding proof that specific natural compounds found in plants have additional conventional medicinal properties. One such compound is xanthohumol (XN), which is being explored as an antimicrobial, anticarcinogenic, antidiabetic and anti-inflammatory agent - aside from its\u00a0utilization in dealing with conditions like autism, bone and skin improvement and microbial infections, lipid-related illnesses, and so on. XN\u00a0is reported to suppress the uncontrolled production of inflammatory mediators responsible for diseases including cardiovascular disease, neurodegeneration\u00a0and tumors. Further, it is accounted to limit adipogenesis and control obesity by focusing on principal adipocyte marker proteins. It is most generally utilized in the brewing industry as an additive and flavoring agent to add bitterness and aroma to beer. Present investigation sum up the patents filed in most recent 2\u00a0years on development of different pharmaceutical mixes and strategies dependent on various therapeutic potentials of XN."]}, "AuthorList": [{"Identifier": ["0000-0001-6920-4341"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Maharishi Markandeshwar (deemed to be University), Mullana, Ambala-133207, Haryana, India."}], "LastName": "Aggarwal", "ForeName": "Diwakar", "Initials": "D"}, {"Identifier": ["0000-0002-1229-4275"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Maharishi Markandeshwar (deemed to be University), Mullana, Ambala-133207, Haryana, India."}], "LastName": "Upadhyay", "ForeName": "Sushil K", "Initials": "SK"}, {"Identifier": ["0000-0002-6331-9196"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Maharishi Markandeshwar (deemed to be University), Mullana, Ambala-133207, Haryana, India."}], "LastName": "Singh", "ForeName": "Raj", "Initials": "R"}, {"Identifier": ["0000-0003-1155-0094"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biotechnology, Maharishi Markandeshwar (deemed to be University), Mullana, Ambala-133207, Haryana, India."}], "LastName": "Tuli", "ForeName": "Hardeep S", "Initials": "HS"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Pharm Pat Anal", "NlmUniqueID": "101582615", "ISSNLinking": "2046-8954"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents, Non-Steroidal"}, {"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}, {"RegistryNumber": "0", "NameOfSubstance": "Chalcones"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "0", "NameOfSubstance": "Hypoglycemic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Propiophenones"}, {"RegistryNumber": "T4467YT1NT", "NameOfSubstance": "xanthohumol"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Anti-Inflammatory Agents, Non-Steroidal"}, {"QualifierName": [], "DescriptorName": "Biological Products"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Bone Diseases"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Chalcones"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Flavonoids"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["chemistry"], "DescriptorName": "Humulus"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Hypoglycemic Agents"}, {"QualifierName": [], "DescriptorName": "Prenylation"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Propiophenones"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2021", "Month": "1", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "9", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "1", "Day": "15", "Hour": "5", "Minute": "33"}], "PublicationStatus": "ppublish", "ArticleIdList": ["33445965", "10.4155/ppa-2020-0026"]}}], "PubmedBookArticle": []}